Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (3y) (2020 - 2024)
Neurocrine Biosciences (NBIX) Interest Coverage Ratio Growth (3y) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.39% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 74.02% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 42.49% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -3.66% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 121.93% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 163.72% |
| Dec 31, 2023 | 145.76% |
| Sep 30, 2023 | 198.62% |
| Jun 30, 2023 | 83.06% |
| Mar 31, 2023 | -154.34% |
| Dec 31, 2022 | 150.90% |
| Sep 30, 2022 | 86.59% |
| Jun 30, 2022 | 78.74% |
| Mar 31, 2022 | 27.92% |
| Dec 31, 2021 | -58.12% |
| Sep 30, 2021 | -1.62% |
| Jun 30, 2021 | 251.74% |
| Mar 31, 2021 | 44.00% |
| Dec 31, 2020 | 79.37% |
| Sep 30, 2020 | -85.45% |
| Jun 30, 2020 | 40.41% |